Clinical Trial Update: Efficacy of Celecoxib 200mg in Relieving Pain and Walking Dysfunction in Osteoarthritis of the Knee [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the efficacy of 200 mg celecoxib for pain relief and walking dysfunction in knee osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Osteoarthritis of the Knee | Phase 2 | Status: UNKNOWN